Daily Morning Note – 21 May 2020
Asian stocks looked set to track an advance on Wall Street as investors focused on signs the American economy will continue to reopen. The dollar dropped.
Futures rose in Japan, Hong Kong and Australia. S&P 500 contracts were little changed after the gauge closed higher Wednesday, with retailers reporting sales that topped estimates and energy shares climbing. Stocks pulled back from session highs after the Senate passed a bill that could bar some Chinese companies from listing on American exchanges, adding to tensions between the nations. Treasuries edged up, while crude oil steadied. The euro rose, coinciding with progress on a $550 billion fiscal-stimulus plan by the European Union.
From June 2, Singapore will gradually allow travellers to transit through Changi Airport as it begins to progressively re-open air transport. In a statement on Wednesday, the Civil Aviation Authority of Singapore (CAAS) said that airlines should submit their proposals for transfer lanes through Changi Airport to it. It added: “The proposals will be evaluated taking into account aviation safety, public-health considerations, as well as the health of passengers and air crew.”
Vicom on Wednesday posted a flat net profit of S$7.3 million for its first quarter ended March 31. Its revenue held steady at S$25.3 million. The vehicle-inspection group said this was because its inspection and testing services businesses had remained stable in the three months before the circuit-breaker measures took effect in April and May.
Manulife US Reit on Wednesday said it has secured a US$100 million Incremental Green Loan Facility from OCBC Bank, the sole lender and green-loan advisor for this transaction. This new five-year term loan is the Reit’s maiden green loan. It was raised under Manulife US Reit’s new green-finance framework, which was developed together with OCBC Bank in line with relevant international principles and guidelines.
Japan Foods on Wednesday said that, based on a preliminary review of its unaudited management accounts, it expects full-year revenue in FY2020 to be comparable to a year ago, but that its net profit after tax will be lower than that in FY2019. The owner of several Japanese food and beverage brands here (such as Ajisen Ramen) is still in the process of finalising the group’s FY2020 unaudited consolidated financial statements. The numbers will be disclosed by end-July.
Source: SGX Masnet, The Business Times, Bloomberg, Channel NewsAsia, Reuters, PSR
Ping An Healthcare and Technology Co Ltd
Recommended Action: Technical BUY
Ping An Healthcare and Technology (HK: 1833) bullish trajectory is gaining momentum and based on the technicals, the stock will continue to rally.
PropNex Limited – Earnings almost tripled but outlook cloudy
Recommendation: BUY (Maintained), Last Done: S$0.495
Target Price: S$0.60, Analyst: Paul Chew
– 1Q20 PATMI jumped almost 3x YoY to S$7.6mn. It beat our expectations. The growth came from three-fold spike in project marketing (i.e. new launches) revenue.
– The outlook will be weak for this year. The circuit breaker, weaker economic conditions and higher priced projects will lead to a contraction in the number of transactions. We cut our FY20e earnings by 19%. Earnings impact will only be registered in 2H20e.
– Net cash continues to pile up to S$89.8mn (+S$10mn YoY) in 1Q20 and almost 50% of the market capitalisation.
– We maintain our BUY recommendation. Our target price is lowered to S$0.60 (previously S$0.70). The outbreak has tempered any growth expectations we had for the company. PropNex retains a healthy market share of around 50% and we expect dividends (S$13mn p.a.) can be maintained with the large cash hoard of S$89.8mn.
HK Reports – Read up on our Hong Kong reports here
Webinar Of The Week
Date: 11 May 2020
|The information contained in this email and/or its attachment(s) is provided to you for information only and is not intended to or nor will it create/induce the creation of any binding legal relations. The information or opinions provided in this email do not constitute an investment advice, an offer or solicitation to subscribe for, purchase or sell the e investment product(s) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. Accordingly, no warranty whatsoever is given and no liability whatsoever is accepted for any loss arising whether directly or indirectly as a result of this information. Investments are subject to investment risks including possible loss of the principal amount invested. The value of the product and the income from them may fall as well as rise. You may wish to seek advice from an independent financial adviser before making a commitment to purchase or investing in the investment product(s) mentioned herein. In the event that you choose not to do so, you should consider whether the investment product(s) mentioned herein is suitable for you. PhillipCapital and any of its members will not, in any event, be liable to you for any direct/indirect or any other damages of any kind arising from or in connection with your reliance on any information in and/or materials attached to this email. The information and/or materials provided 揳s is?without warranty of any kind, either express or implied. In particular, no warranty regarding accuracy or fitness for a purpose is given in connection with such information and materials.|
|This e-mail and its attachment(s) may contain privileged or confidential information, which is intended only for the use of the recipient(s) named above. If you have received this message in error, please notify the sender immediately and delete all copies of it. If you are not the intended recipient, you must not read, use, copy, store, disseminate and/or disclose to any person this email and any of its attachment(s). PhillipCapital and its members will not accept legal responsibility for the contents of this message. Thank you for your cooperation.|